Explore SS-31 and Elamipretide, mitochondrial research, Barth syndrome clinical evidence, Forzinity approval, and limits of broader research claims.
Elamipretide is also known by research names SS-31, MTP-131, and Bendavia. Forzinity names a particular FDA-approved elamipretide medicine.
It is a synthetic tetrapeptide studied in mitochondrial biology. Laboratory materials and the approved formulation are different product contexts.
Research investigates mitochondrial inner-membrane interactions and bioenergetic function. A mechanism does not establish effectiveness across all mitochondrial or aging conditions.
Clinical development includes Barth syndrome and other disease-specific studies. Results must be interpreted by indication rather than generalized to wellness claims.
FDA granted Forzinity accelerated approval on September 19, 2025 to improve muscle strength in Barth syndrome patients weighing at least 30 kg. This limited approval does not authorize every SS-31 product or use.
FDA granted accelerated approval to Forzinity for a defined Barth syndrome population in September 2025. The agency describes continuing confirmatory research as part of the accelerated-approval pathway. FDA, Forzinity approval
The FDA prescribing information identifies the approved formulation, indication, and safety information. These boundaries should accompany discussion of elamipretide and must not be extended to unapproved research preparations or general anti-aging use. FDA, Forzinity prescribing information
Current programs, research areas, study status, enrollment, and expected completion dates organized from primary registry records.
Age Related Macular Degeneration (ARMD)
Barth Syndrome
Aging, Healthy
SS-31 peptide benefits center on mitochondrial protection. Learn how elamipretide works, what research shows, dosing, side effects, and safety considerations.
N-acetyl SS-31 is a mitochondria-targeted research peptide known as elamipretide. See how it works, its FDA status, stacking with MOTS-c, and safety notes.
Elamipretide structure explained: the D-Arg-Dmt-Lys-Phe-NH2 tetrapeptide sequence, its molecular formula, net charge, and how it targets mitochondria.
SS-31 peptide benefits include mitochondrial energy support and reduced oxidative stress in research. Learn what studies show about dosing and safety.
Learn how the MOTS-c SS-31 stack works, why researchers study these mitochondrial peptides together, and key protocol timing and safety notes.
SS-31 peptide dosing varies widely in research, with no FDA-approved human dose in the US. Compare reported protocols, routes, and safety caveats.
Wondering if you can take SS-31 and MOTS-c together? Learn what research says about the stack, dosing gaps, safety risks, and why no human trial exists.
SS-31 HA usually means the mitochondria-targeted peptide SS-31 combined with hyaluronic acid. Learn how it's studied, dosed, and stacked with MOTS-c.
SS-31 for sale listings are research-only. Learn what elamipretide is, typical lab handling, purity checks, and how to vet peptide vendors in the USA.
Looking for where to buy SS-31 peptide? Compare COA standards, purity testing, storage, and red flags before choosing a research peptide supplier.
SS-31 peptide, also called elamipretide, is a mitochondria-targeted research peptide. Learn what studies show, its FDA status, and safety concerns.
SS-31 peptide price ranges from about $40 to $150 per vial depending on size, purity, and vendor. Here's how to compare cost, quality, and COAs.
Looking to buy SS-31 peptide for laboratory research? Learn how elamipretide is supplied, what purity checks matter, and what US rules apply.
Looking for SS 31 peptide for sale online? Learn how to vet vendors, understand legal status, dosing research, and safety before you first buy.
This ss-31 and mots-c protocol guide covers typical dosing, reconstitution, stacking schedules, side effects, and why neither peptide is FDA-approved.
SS-31 peptide subQ dosage is a research-only topic. Learn how elamipretide is studied, typical lab protocols, and why no human dose is established.
Thinking about running SS-31 before MOTS-c? Learn how these research peptides are typically sequenced, why timing matters, and what safety questions remain.
Elamipretide hydrochloride is an investigational mitochondria-targeted peptide. Here's how it works, what conditions it targets, its FDA status, and cost.
SS-31 peptide benefits center on mitochondrial support, and early research explores kidney, heart, and muscle effects. Here's what human trials show so far.
SS-31 side effects reported in trials include injection site reactions, headaches, and fatigue. Learn what the research shows and when to talk to a doctor.